Overview
This page focuses on how to think about basic dose and exposure concepts in an abstract way for CJC-1295 + Ipamorelin and similar peptides. It does not provide dosing instructions or protocols.
Key themes in dosing concepts
- Understanding vial amount, dilution volume, and resulting concentration.
- Relating concentration to an abstract "unit" or hypothetical dose.
- Recognizing that pharmacokinetics (absorption, distribution, metabolism, elimination) influence exposure beyond simple vial math.
Context and caveats
Any concrete dosing decisions for CJC-1295 + Ipamorelin must be grounded in product labelling (where it exists), formal clinical guidance, and individualized medical judgment. Educational tools such as calculators and half-life plotters are best treated as aids for understanding, not as dosing engines.
Sport & Anti-Doping Warning
Stacks that combine CJC-1295 with ipamorelin mirror protocols that have drawn scrutiny from anti-doping agencies because they simultaneously stimulate GHRH and GHRP pathways to increase growth hormone output.
Even if sold as a single vial, a combination of two prohibited GH-axis peptides is treated as multiple violations under most anti-doping codes.